Two New Appointees at the NCI
BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology, Thomas Jefferson University, Philadelphia, has been appointed chief of NCI's Radiation Research Program. She is former president of the American Radium Society and the American Cancer Society, Philadelphia Division.
BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology,Thomas Jefferson University, Philadelphia, has been appointedchief of NCI's Radiation Research Program. She is former presidentof the American Radium Society and the American Cancer Society,Philadelphia Division.
Kenneth Cowan, MD, head of the NCI Medicinal Breast Cancer Section,will serve as acting chief of the Medicine Branch, temporarilyreplacing Robert Wittes, MD, acting director of the Division ofCancer Treatment.
Giredestrant Combo Yields Positive PFS in Subgroups After CDK4/6i in ER+/HER2– Breast Cancer
December 13th 2025“The magnitude of clinical benefit was clinically meaningful and consistent, and was regardless of PIK3CA mutations or alterations in the PIK3CA pathway, duration of prior CDK4/6 inhibitors, including patients who progress within 6 to 12 months, and the choice of prior CDK4/6 inhibitors,” said Hope S. Rugo, MD.
